Download
cancer cervix screening at the infectious diseases institute n.
Skip this Video
Loading SlideShow in 5 Seconds..
Cancer cervix screening at the infectious diseases institute PowerPoint Presentation
Download Presentation
Cancer cervix screening at the infectious diseases institute

Cancer cervix screening at the infectious diseases institute

519 Vues Download Presentation
Télécharger la présentation

Cancer cervix screening at the infectious diseases institute

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. INFECTIOUS DISEASES INSTITUTE Cancer cervix screening at the infectious diseases institute ShadiaNakalema 10/10/2012

  2. Introduction • Uganda • Overall HPV Prevalence in Uganda is 16.7% (David serwadda et al 1997 JID) • HIV +ve 44.7% • HIV –ve 10.2% • HIV prevalence rate amongst women 15-45yrs – 6.7 • Highest worldwide CaCx incidence rate (45.6/10000)

  3. IDI background • 10000 patients all HIV positive • 6756 (67%) females • 7,176 (71%) on ART

  4. Background of IDI program • SRH program started in 2008 • Integrated PMTCT • Family planning • STI diagnosis and treatment • Cancer cervix screening • Funded by TIDES/INTERACT

  5. Methods • Screening is voluntary. • Identification points; • Patients waiting area (health talks) • Nurses station • Doctors consultations • Performed by the SRH doctor or Nurse • Technique used is Visual Inspection with 2% Acetic acid (VIA)

  6. Methods • Additional data about risk factors recorded • Age, parity, sexual début, number of life long sexual partners and previous VIA results • Positive VIA - referred to gynae-oncology • Negative VIA – health information given to encourage yearly screening

  7. Results • No screened (Jan 2011 to date)- 322 • Median age - 38yrs • % on ART- 71% • Median CD4- 416cells/ul • No positive – 84 (26.1%)

  8. Age

  9. Sexual Debut

  10. Parity

  11. Number of lifelong partners

  12. Successes • Well trained / experienced staff • (Dr and Nurse) for SRH • Accessed dedicated space and equipment. • Increased cervical cancer awareness amongst staff and pts – interaction HIV & HPV

  13. Challenges • Patient education • Patient concerned about follow up care • Relying on patients to return their histology results to the clinic means many may be missed • There is no proper referral system for patients with positive VIAs

  14. THANK YOU